Evidence map›Paper›PMID 26195742›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Replacing SNAP-25b with SNAP-25a expression results in metabolic disease.

Ismael Valladolid-Acebes, Teresa Daraio, Kerstin Brismar, Tibor Harkany, Sven Ove Ögren, Tomas G M Hökfelt, Christina Bark

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Biological psychiatry global open science · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Upregulation ofFrontiers in endocrinology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Ismael Valladolid-AcebesDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden; Ismael.Valladolid.Acebes@ki.se tomas.hokfelt@ki.se Christina.Bark@ki.se.
Teresa DaraioDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden;
Kerstin BrismarDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden;
Tibor HarkanyDivision of Molecular Neurosciences, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria.
Sven Ove ÖgrenDepartment of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden;
Tomas G M HökfeltDepartment of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden; Ismael.Valladolid.Acebes@ki.se tomas.hokfelt@ki.se Christina.Bark@ki.se.
Christina BarkDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Ismael.Valladolid.Acebes@ki.se tomas.hokfelt@ki.se Christina.Bark@ki.se.
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synaptosomal-associated protein of 25 kDa (SNAP-25) is a key molecule in the soluble N-ethylmaleimide-sensitive factor attachment protein (SNARE) complex mediating fast Ca(2+)-triggered release of hormones and neurotransmitters, and both splice variants, SNAP-25a and SNAP-25b, can participate in this process. Here we explore the hypothesis that minor alterations in the machinery mediating regulated membrane fusion can increase the susceptibility for metabolic disease and precede obesity and type 2 diabetes. Thus, we used a mouse mutant engineered to express normal levels of SNAP-25 but only SNAP-25a. These SNAP-25b-deficient mice were exposed to either a control or a high-fat/high-sucrose diet. Monitoring of food intake, body weight, hypothalamic function, and lipid and glucose homeostases showed that SNAP-25b-deficient mice fed with control diet developed hyperglycemia, liver steatosis, and adipocyte hypertrophy, conditions dramatically exacerbated when combined with the high-fat/high-sucrose diet. Thus, modified SNARE function regulating stimulus-dependent exocytosis can increase the vulnerability to and even provoke metabolic disease. When combined with a high-fat/high-sucrose diet, this vulnerability resulted in diabesity. Our SNAP-25b-deficient mouse may represent a diabesity model.

Indexed as

AdipocytesAdipose Tissue, WhiteAdiposityAnimalsBlood GlucoseBody WeightDyslipidemiasEnergy IntakeEnergy MetabolismFeeding BehaviorFemaleHomeostasisHypertrophyHypothalamusInsulinInsulin SecretionBlood GlucoseInsulinLeptinReceptors, LeptinSnap25 protein, mouseSynaptosomal-Associated Protein 25glucose metabolismhypothalamusinsulin secretionregulated exocytosisSNARE

Identifiers

PMID26195742
PMCPMC4534236
OpenAlexW1828476563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.